These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 19124599)

  • 1. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins in the elderly: what evidence of their benefit in prevention?
    Steg PG; Tissot CM
    Arch Cardiovasc Dis; 2010 Feb; 103(2):61-5. PubMed ID: 20226424
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on statins and other lipid-lowering drugs.
    Miller CA
    Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910
    [No Abstract]   [Full Text] [Related]  

  • 5. From here to JUPITER: identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination Survey.
    Spatz ES; Canavan ME; Desai MM
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):41-8. PubMed ID: 20031811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A triumvirate of targets in the prevention and treatment paradigm for cardiovascular disease.
    Packard C
    Atheroscler Suppl; 2006 Apr; 7(1):21-9. PubMed ID: 16504600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statins with a perspective of lifelong therapy].
    Ertaş FS
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.
    Balbisi EA
    Med Sci Monit; 2006 Feb; 12(2):RA34-9. PubMed ID: 16449961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
    Goumas GS
    Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention trials: lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular disease.
    Ferdinand KC
    Curr Med Res Opin; 2005 Jul; 21(7):1091-7. PubMed ID: 16004678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk.
    Nieuwkerk PT; Nierman MC; Vissers MN; Locadia M; Greggers-Peusch P; Knape LP; Kastelein JJ; Sprangers MA; de Haes HC; Stroes ES
    Am J Cardiol; 2012 Sep; 110(5):666-72. PubMed ID: 22621795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal management of hyperlipidemia in primary prevention of cardiovascular disease.
    Raza JA; Babb JD; Movahed A
    Int J Cardiol; 2004 Dec; 97(3):355-66. PubMed ID: 15561319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence and critique of the JUPITER Trial (Statins v no statins for primary prevention of cardiovascular events in patients with normal lipids and elevated C-reactive protein).
    Samson RH; Nair DG
    Semin Vasc Surg; 2011 Sep; 24(3):172-9. PubMed ID: 22153029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy in the elderly: a review.
    Szadkowska I; Stanczyk A; Aronow WS; Kowalski J; Pawlicki L; Ahmed A; Banach M
    Arch Gerontol Geriatr; 2010; 50(1):114-8. PubMed ID: 19217673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidemias and the primary prevention of cardiovascular disease: analysis of the FAMUS primary care register.
    Xhignesse M; Laplante P; Niyonsenga T; Courteau J; Grant AM
    Can J Cardiol; 2000 Jul; 16(7):879-85. PubMed ID: 10934306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin prescription in men and women at cardiovascular risk: to whom and when?
    Brugts JJ; Deckers JW
    Curr Opin Cardiol; 2010 Sep; 25(5):484-9. PubMed ID: 20625281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.
    Mann D; Reynolds K; Smith D; Muntner P
    Ann Pharmacother; 2008 Sep; 42(9):1208-15. PubMed ID: 18648016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid lowering therapy in atherosclerosis.
    Aikawa M; Libby P
    Semin Vasc Med; 2004 Nov; 4(4):357-66. PubMed ID: 15861316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model.
    Mason CM
    J Am Acad Nurse Pract; 2009 Jan; 21(1):47-53. PubMed ID: 19125895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.